Parkinson's Disease

Pfizer has announced plans to end its research efforts to discover new drugs for Alzheimer's and Parkinson's diseases. The pharmaceutical giant explained its decision, which will entail roughly 300 layoffs, as a move to better position itself "to bring new therapies to patients who need them."

A drug that's already approved for treating leukemia appears to dramatically reduce symptoms in people who have Parkinson's disease with dementia, or a related condition called Lewy body dementia.

A pilot study of 12 patients given small doses of nilotinib found that movement and mental function improved in all of the 11 people who completed the six-month trial, researchers reported Saturday at the Society for Neuroscience meeting in Chicago.

asbruff / Flickr (Creative Commons License)

A Georgetown man is benefiting from a portable infusion pump that delivers a drug to treat his Parkinson's disease symptoms.  The device is designed for patients who have seen little success with traditional, oral methods.  

70 year-old Marion Cox participated in a University of Kentucky clinical trial.  He says the drug delivery method has made a big impact on his life.

A team of doctors at the University of Kentucky will investigate new treatments for patients with Parkinson’s disease.   It potentially could reverse the brain damage done by Parkinson’s.